George Magrath
Chief Executive Officer at Opus Genetics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Opus Genetics Inc., 1 year.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Opus Genetics Inc. April 20, 202699.5%
-
Opus Genetics Inc. April 30, 202587.5%
-
Opus Genetics Inc. June 11, 202471.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | Opus Genetics Inc. | Option exercise | +392,157 | $1.15 | $450,981 |
| Sep 9, 2026 | Opus Genetics Inc. | Shares withheld for tax | −75,541 | $5.97 | $450,980 |
| Jul 23, 2026 | Opus Genetics Inc. | Open-market sale | −9,475 | $2.95 | $27,926 |
| Apr 23, 2026 | Opus Genetics Inc. | Open-market sale | −9,511 | $5.22 | $49,647 |
| Mar 16, 2026 | Opus Genetics Inc. | Open-market sale | −24,438 | $5.21 | $127,322 |
| Jan 22, 2026 | Opus Genetics Inc. | Grant or award | +483,639 | — | — |
| Nov 1, 2025 | Opus Genetics Inc. | Shares withheld for tax | −30,350 | $2.30 | $69,805 |
| Mar 24, 2025 | Opus Genetics Inc. | Grant or award | +392,157 | — | — |
| Mar 13, 2025 | Opus Genetics Inc. | Grant or award | +330,697 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.